BrightSpring Health Services, Inc. (NASDAQ:BTSG) Stock Has Consensus Target Price of $70.71

BrightSpring Health Services, Inc. (NASDAQ:BTSG) has been given an average rating of “Buy” by the twenty analysts that are currently covering the firm, MarketBeat.com reports. Eighteen research analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The average 1-year price objective among analysts that have covered the stock in the last year is $70.71.

A number of brokerages recently issued reports on BTSG. TD Cowen lifted their price target on shares of BrightSpring Health Services from $65.00 to $81.00 and gave the company a “buy” rating in a research report on Thursday, June 18th. UBS Group upped their price objective on shares of BrightSpring Health Services from $63.00 to $85.00 and gave the stock a “buy” rating in a report on Wednesday, July 8th. The Goldman Sachs Group started coverage on shares of BrightSpring Health Services in a research note on Monday, June 8th. They set a “buy” rating and a $71.00 target price for the company. Raymond James Financial began coverage on shares of BrightSpring Health Services in a report on Thursday, July 9th. They set an “outperform” rating and a $80.00 target price for the company. Finally, KeyCorp reissued an “overweight” rating on shares of BrightSpring Health Services in a research report on Monday, August 3rd.

BrightSpring Health Services Price Performance

BTSG opened at $60.25 on Friday. The stock has a fifty day simple moving average of $60.26 and a two-hundred day simple moving average of $57.97. The company has a current ratio of 1.59, a quick ratio of 1.22 and a debt-to-equity ratio of 1.06. The company has a market cap of $11.92 billion, a price-to-earnings ratio of 36.30, a price-to-earnings-growth ratio of 0.70 and a beta of 1.87. BrightSpring Health Services has a 12-month low of $27.11 and a 12-month high of $73.75.

BrightSpring Health Services (NASDAQ:BTSG) last announced its quarterly earnings data on Friday, July 31st. The company reported $0.45 EPS for the quarter, beating the consensus estimate of $0.40 by $0.05. The business had revenue of $3.87 billion during the quarter, compared to analyst estimates of $3.66 billion. BrightSpring Health Services had a return on equity of 16.73% and a net margin of 2.55%.The company’s revenue for the quarter was up 23.0% on a year-over-year basis. During the same quarter last year, the firm posted $0.22 earnings per share. Research analysts predict that BrightSpring Health Services will post 1.64 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the stock. Allworth Financial LP purchased a new stake in BrightSpring Health Services during the 2nd quarter valued at about $28,000. IFP Advisors Inc grew its holdings in shares of BrightSpring Health Services by 204.5% in the second quarter. IFP Advisors Inc now owns 606 shares of the company’s stock worth $42,000 after acquiring an additional 407 shares during the period. GHP Investment Advisors Inc. purchased a new stake in shares of BrightSpring Health Services during the 1st quarter valued at about $31,000. Kilter Group LLC purchased a new stake in BrightSpring Health Services during the second quarter valued at approximately $50,000. Finally, Public Employees Retirement System of Ohio purchased a new stake in shares of BrightSpring Health Services in the 2nd quarter worth $63,000.

About BrightSpring Health Services

BrightSpring Health Services, Inc is a U.S. provider of pharmacy and health services focused on individuals with complex or chronic medical needs. The company delivers care across home and community-based settings, serving older adults, people with disabilities, and patients requiring specialized support.

Its services include pharmacy care through PharMerica, home health and hospice, primary and urgent care, behavioral health, rehabilitation, and personal care. BrightSpring also provides residential and community-based services, including assistance with daily living, clinical support, and care coordination for individuals who need ongoing support outside traditional hospital settings.

The company was formed in 2019 through the combination of PharMerica and ResCare.